Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Changzhou
Clinical trial register · China

Clinical Trials in Changzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Changzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC21 AstraZeneca14 Eli Lilly and Company12 The First People's Hospital of Changzhou5 The First Affiliated Hospital with Nanjing Medical University5 Changzhou No.2 People's Hospital5 Novo Nordisk A/S3 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3 Nanjing Medical University3 Hoffmann-La Roche2 Takeda2 Daiichi Sankyo2 Ausper Biopharma Co., Ltd.2 Peking Union Medical College Hospital1 Xi Shan Wang1 BeOne Medicines1 Inmunotek S.L.1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Xian-Janssen Pharmaceutical Ltd.1 Shanghai Best-Link Bioscience, LLC1 Wu Jun1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 Tianjin Medical University General Hospital1 Hua Jiang1 Alexion Pharmaceuticals, Inc.1 Hong Kong Metropolitan University1 Biotheus Inc.1 Jiangsu Cancer Institute & Hospital1 InnoCare Pharma Inc.1 UCB Biopharma SRL1 WEI XU1 NewAmsterdam Pharma1 Shanghai Tong Ren Hospital1 Sinovac Biotech Co., Ltd1 Evopoint Biosciences Inc.1 Sanofi1 Beijing 302 Hospital1 ShanShan Li1 Novartis Pharmaceuticals1 Bristol-Myers Squibb1 Boehringer Ingelheim1 The First Affiliated Hospital of Soochow University1 Yun Ye1 Jazz Pharmaceuticals1 China Academy of Chinese Medical Sciences1 Fudan University1 National Research Institute for Family Planning, China1 Nanjing IASO Biotechnology Co., Ltd.1 GlaxoSmithKline1 Shanghai Henlius Biotech1 Xuanwu Hospital, Beijing1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 RemeGen Co., Ltd.1 Cai gaojun, MD1 Celgene1 AbbVie1 Amgen1 Dizal Pharmaceuticals1 Clear sponsor filter
Site location
Changzhou1
All 1 locations
Target enrolment
to

Trials with a site in Changzhou

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Yun Ye
Observational
600
Changzhou
2025-12-24
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/changzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Changzhou that also match the filters currently applied.

How many clinical trials are recruiting in Changzhou?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Changzhou), 1 studies
PhaseStudiesRecruitingShare
Observational11100%

Most active sponsors

Lead sponsors with the most studies (Changzhou)
Lead sponsorStudiesRecruiting
Yun Ye11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.